BWXT Hosting Investor Day on Nov. 16

(LYNCHBURG, Va. – Nov. 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) is hosting an Investor Day 8:30 a.m. to approximately 11:30 a.m. ET on Tuesday, Nov. 16, 2021. During the event, BWXT executives will discuss current operations and future vision across the company’s portfolio of businesses. There will also be a question and answer […]

BWXT Names Robb A. LeMasters as Next Chief Financial Officer

Current CFO David Black to Retire After 30 Years at BWXT and Serve as Special Advisor to CEO LYNCHBURG, Va. — BWX Technologies, Inc. (NYSE: BWXT) announced today that as part of BWXT’s executive succession planning process, Robb A. LeMasters has been named senior vice president and chief financial officer effective November 15, 2021. LeMasters will […]

OPG awards contract for complex parts for nuclear refurbishment

Peterborough – Ontario Power Generation (OPG) and BWX Technologies, Inc. (NYSE: BWXT) are announcing a contract for Fuelling Machine (FM) head engineering and component supply as part of refurbishment of the Darlington Nuclear Generating Station. The contract will be formally announced today at BWXT’s Peterborough, Ontario, facility, with Energy Minister Todd Smith, Peterborough-Kawartha MPP Dave Smith, […]

BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity

Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]

BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies […]

BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

(CAMBRIDGE, ON – August 19, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.  The contract, which will be executed by subsidiary BWXT Canada Ltd. at its Cambridge, Ontario facility, involves engineering and fabrication of these specialized components. Moderator […]

BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.  Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions […]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.